Significant progress in the battle against pancreatic cancer is emerging, thanks to a new medical breakthrough. An experimental drug, administered once daily, is showing potential in extending the lives of patients by slowing the advance of this highly lethal disease.
Dr. Rachna Shroff, who serves as the associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, discusses the promising outcomes with Stephanie Sy. The research indicates that this innovative treatment could represent a major step forward after years of dedicated study.
About Stephanie Sy
Stephanie Sy is currently a correspondent for PBS News Hour. She has extensive experience in journalism, having held positions as an anchor and correspondent for major networks including ABC News, Al Jazeera America, CBSN, CNN International, and PBS News Hour Weekend. Before her current role, she worked with Yahoo News where she covered the 2018 Midterm Elections and reported live from Donald Trump’s victory party on Election Day 2016.
Philadelphia Reports Measles Exposures at Airport and Hospital 
Legal Challenges Arise Over GLP-1 Receptor Agonists and Vision Loss Risks 
States Move to Restrict Tianeptine Amid Growing Concerns 
Potential Changes in Medicare Reimbursement for Lab Tests 
Understanding and Addressing the Complexity of Suicide 
Recall of Meat Products from Star Meat Delivery Inc.